Bone marrow stem cell mobilization to the peripheral blood and tumor necrosis factor-α expression in ischemic myocardium in rabbit models of hibernating myocardium 兔冬眠心肌模型骨髓干细胞动员及心肌组织中肿瘤坏死因子基因表达
Objective To study the correlation between blood serum tumor markers and TCM syndromes of colorectal cancer. 目的研究血清肿瘤标志物的变化与结直肠癌中医辨证分型的相关性。
Method Frozen therapy is proceed on 46 cases of patients suffering blood vessel tumor or naevus with pigment, which is making use of frozen of the liquid nitrogen and oxygen (-186 centigrade). 方法应用液体氮、氧(-186℃)对46例眼睑、脸部血管瘤色素痣病人进行冷冻治疗。
Infection Case of HHV? 7 in Blood Tumor Patients 人类疱疹病毒7型在血液肿瘤患者中感染情况
Detection of 12 tumor markers in peripheral blood of tumor patients 肿瘤标志物12项在肺癌患者外周血的表达
Peripheral Blood Tumor Markers in Breast Cancer and Their Application to Follow-up 乳腺癌外周血肿瘤标志物及其在随访中的应用
Y-27632 inhibits the opening of blood tumor barrier caused by bradykinin Y-27632抑制缓激肽选择开放血肿瘤屏障的研究
The analysis of 46 cases frozen therapy against blood vessel tumor, naevus with pigment 冷冻治疗脸部血管瘤、色素痣46例诊疗分析
Since I was found to have a large Blood Tumor near my chest that required immediate attention, therefore, I am one of the lucky one that was selected into the "HKAAC Stray Animal Rescue program". 我是一只流浪狗,是香港动物领养中心“流浪狗”计划之中的一员,我被发现时在肋骨位置生了一个大血瘤。
The Direct Cytotoxic Effect of Activated Dendritic Cell Derived from Cord Blood on Tumor Cells 激活的脐血树突状细胞对肿瘤细胞的直接杀伤作用
Relationship between the expression of GPC-3 mRNA in peripheral blood and tumor micrometastasis in patients with primary hepatocellular carcinoma 原发性肝癌患者外周血GPC-3mRNA的表达与微转移的关系
Methods The ultrastructure of blood tumor barrier in gliomas was observed by transmission electronic microscope. 方法应用透射电镜观察脑胶质瘤侵袭微生态系统中血瘤屏障的超微结构改变;
Severity of Systemic Inflammatory Response to Type B Epidemic Encephalitis and Blood Tumor Necrosis Factor Complicated with Respiratory Failure 流行性乙型脑炎患儿炎症反应水平、血肿瘤坏死因子和并发呼吸衰竭的相关性
Preparation of Red Blood Cell Tumor Vaccine and its Effects on Tumor Recurrence and metastasis 红细胞肿瘤疫苗的制备及对肿瘤复发转移作用的观察
Conclusions The overexpression of MMP 2 and MMP 9 may be correlated with the remodelling of blood tumor barrier in human brain glioma. 结论MMP-2、MMP-9与人脑胶质瘤侵袭微生态系统中血瘤屏障的改造重建有关。
High tumor to blood, tumor to brain, tumor to heart, tumor to stomach, tumor to muscle radioactivity ratios were obtained. 有较高的肿瘤/血液、肿瘤/脑、肿瘤/心脏、肿瘤/胃及肿瘤/肌肉放射性比值。
The basis for bradykinin's selective modulation of the blood tumor barrier 缓激肽选择性调节血肿瘤屏障的内在基础
Bradykinin and its analog RMP-7 significantly increase the permeability of the blood tumor barrier, but is unaffected for the normal blood brain barrier. 缓激肽及其类似物RMP-7能选择性增加血肿瘤屏障的通透性,而对正常脑组织的血脑屏障几乎无影响。
Meropenem in Treating Blood Tumor Combined with Infection in Children: Effect and Analysis 美罗培南治疗儿童肿瘤疾病合并感染的疗效评价
CONCLUSIONS Tienam has characteristics of rapid and obvious efficacy in treating patients suffered from blood tumor combined with the infection. 总有效患者为232例(80.7%)。结论应用亚胺培南/西司他丁治疗血液肿瘤合并感染的患者,具有疗效快、作用显著之特点。
Objective To investigate the mechanism of selective opening of blood tumor barrier by bradykinin and to find out its indication factors. 目的探讨缓激肽能选择性地诱发肿瘤血脑屏障开放的机理及影响此种开放的因素。
Objective To study the mechanism of selective opening blood tumor barrier by bradykinin in rat cerebral glioma model. 目的研究缓激肽选择性开放脑肿瘤的血肿瘤屏障的机制。
Objective: to study the effect of of blood on tumor's hepatic metastasis, we duplicated stasis on the mice. 目的:以荷B16黑色素瘤细胞的血瘀证小鼠为研究对象,观察血瘀状态下恶性肿瘤肝转移的特点。
Objective: To detect the frequency of Treg in peripheral blood and tumor tissue of patients with renal cell carcinoma. 目的:检测肾癌患者外周血和肿瘤组织内调节性T淋巴细胞比例。
The secretion of IL-1 β can be increased in C6 glioma cells induced by bradykinin, which may play an important role in the process of bradykinin augmenting the permeability of the blood tumor barrier. 3. 缓激肽可刺激大鼠C6胶质瘤细胞中IL-1β的分泌增强,IL-1β的表达上调可能在缓激肽增加血肿瘤屏障通透性的过程中发挥一定作用。
But in tumor tissue and peripheral blood of tumor patients, amount of DCs decreases, of which maturity and function is inhibited. DC在肿瘤免疫中的功能强大,但肿瘤组织及外周血中DC的数目、成熟及功能受到抑制。
To make the blood tumor cell contact with fibronectin simulating the bone marrow microenvironment in vivo, to validate if fibronectin has mediated the minimal residual disease of blood tumor cells, namely tumor resistance. Methods: 1. 模拟体内肿瘤细胞与骨髓基质中纤维连接蛋白接触模型,验证纤维连接蛋白是否介导了血液肿瘤微小残留病灶的产生,即肿瘤耐药。
It is reported that MDSCs are elevated in peripheral blood and tumor tissues of cancer patients and also in bone marrow, spleen, blood and tumor tissues of tumor-bearing mice. 研究发现,MDSCs在癌症患者的外周血以及荷瘤小鼠的骨髓、血液和脾脏中显著增加,肿瘤组织中也有浸润。